Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label Sofosbuvir/Cost. Show all posts
Showing posts with label Sofosbuvir/Cost. Show all posts
Friday, March 1, 2019

Companies, states interested in Louisiana Netflix-style hepatitis C plan

›
Companies, states interested in Louisiana hepatitis C plan By MELINDA DESLATTE Associated Press BATON ROUGE, La. Three drug compan...
Friday, February 15, 2019

Hepatitis C and HIV/AIDS Medications Costliest Group of Outpatient Prescription Drugs for Medicaid

›
Kaiser Family Foundation Analysis Finds that Medications for Hepatitis C and HIV/AIDS Are the Costliest Group of Outpatient Prescription Dr...
Thursday, February 14, 2019

Netflix Model -Countries Use Novel Strategies to Tackle Price of HCV Drugs

›
Countries Use Novel Strategies to Tackle Price of HCV Drugs Roxanne Nelson, RN, BSN February 14, 2019 A recent study suggests that the ...
Thursday, February 7, 2019

Impact of Hepatitis C Virus and Insurance Coverage on Mortality

›
The American Journal of Managed Care February 2019 Impact of Hepatitis C Virus and Insurance Coverage on Mortality Haley Bush, MSPH; Ja...
Wednesday, February 6, 2019

HCV Special Conference - Worldwide HCV Epidemiology and Impact of Treatment

›
Website   AASLD / EASL HCV Special Conference February 1-2, 2019  The goal of the conference is to promote global elimination of hep...
Monday, February 4, 2019

Gilead's hepatitis C generics are on their way, but Epclusa's getting TV ads anyway

›
Gilead's hepatitis C generics are on their way, but Epclusa's getting TV ads anyway  by Beth Snyder Bulik | Feb 4, 2019  Gilea...
Sunday, February 3, 2019

Interferon-free hepatitis C therapies: barriers to adherence and optimizing treatment outcomes

›
Research Article Experiences with interferon-free hepatitis C therapies: addressing barriers to adherence and optimizing treatment outcom...
Saturday, February 2, 2019

Hepatitis C - Generic DAAs achieve excellent cure rates in Egypt

›
Source: infohep Treatment Outcomes Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of th...
Friday, February 1, 2019

The Cost of Cure: Barriers to Access for Hepatitis C Virus Treatment in South Texas

›
In case you missed it EDITORIALS  DOI: 10.1200/JOP.18.00525 Journal of Oncology Practice Published online before print January 22, 2019...

Hepatitis C: Out-of-Pocket Cost Burden for Specialty Drugs in Medicare Part D in 2019

›
Published: Feb 01, 2019  The Out-of-Pocket Cost Burden for Specialty Drugs in Medicare Part D in 2019 Juliette Cubansk, Wyatt Koma, and...
Wednesday, January 16, 2019

No-haggle policy on drug pricing cost Medicare at least $14.4B

›
Becker's Hospital Review No-haggle policy on drug pricing cost Medicare at least $14.4B, study finds Written by Alia Paavola | Jan...
Saturday, January 12, 2019

HCV requires serious policies and affordable insurance coverage

›
Of Interest Q&A: DAA restrictions impact patient care January 14, 2019 Infectious Disease News spoke with Breskin about why DAAs rest...
Friday, January 11, 2019

Iowa Medicaid Expands Care To Hepatitis C Patients, But Restrictions Remain

›
Iowa Medicaid Expands Care To Hepatitis C Patients, But Restrictions Remain By Kate Payne   Starting this month more hepatitis C patient...

Louisiana adopts ‘Netflix’ model to pay for hepatitis C drugs

›
Washington Post : To Your Health - January 10, 2019  Louisiana adopts ‘Netflix’ model to pay for hepatitis C drugs Louisiana will use...
Sunday, January 6, 2019

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

›
Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C By Carmen Heredia Rodriguez January 4, 2019 Drugs t...
Wednesday, December 5, 2018

Appeal lodged against decision to uphold Gilead’s patent on hepatitis C drug

›
Video - The story of sofosbuvir illustrates how research and development for new prescription drugs really works: When Big Pharma plays fo...
Tuesday, November 27, 2018

Wall Street - Curing diseases like Hepatitis C just doesn’t pay

›
On This Blog The controversy over expensive new drugs for hepatitis C Link to a collection of current articles regarding the effectivenes...
Sunday, November 25, 2018

In a Critical State: Ongoing Barriers to Treatment for Hepatitis C Virus (HCV)

›
Editorial In a Critical State: Ongoing Barriers to Treatment for Hepatitis C Virus (HCV) Jorge Mera, MD, Brigg Reilley, MPH, Jessica Les...
Saturday, November 24, 2018

In half of hepatitis C patients, DAA treatment can shortened to 6 weeks

›
Recommended  Media Hepatitis C treatment can be shortened in 50 percent of patients, study finds Shorter treatment times could significan...
Thursday, November 22, 2018

Blogging About Liver Disease: Reasons To Be Grateful

›
Happy Thanksgiving! This year, and every year, I am grateful for a small group of talented bloggers who continue to keep us informed abo...